Cargando…

Clinical Case: Patient with Mixed Graft Rejection Four Days after Kidney Transplantation Developed Specific Antibodies against Donor Bw4 Specificities

Kidney transplantation, like other transplants, has the risk of producing graft rejection due to genetic differences between donor and recipient. The three known types of renal rejection are listed in the Banff classification: T-cell-mediated rejection (TCMR), antibody-mediated rejection (ABMR), and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muñoz-Herrera, Claudia M., Gutiérrez-Bautista, Juan Francisco, López-Nevot, Miguel Ángel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395409/ https://www.ncbi.nlm.nih.gov/pubmed/34449522 http://dx.doi.org/10.3390/antib10030028

Ejemplares similares

Complement Binding Anti-HLA Antibodies and the Survival of Kidney Transplantation
por: Muñoz-Herrera, Claudia M., et al.
Publicado: (2023)

Characteristics of Donor-Specific Antibodies Associated With Antibody-Mediated Rejection in Lung Transplantation
por: Roux, Antoine, et al.
Publicado: (2017)

The Number of Donor-Specific IL-21 Producing Cells Before and After Transplantation Predicts Kidney Graft Rejection
por: van Besouw, Nicole M., et al.
Publicado: (2019)

High tacrolimus intra-patient variability is associated with graft rejection, and de novo donor-specific antibodies occurrence after liver transplantation
por: Del Bello, Arnaud, et al.
Publicado: (2018)

Pretransplant Donor-Specific Anti-HLA Antibodies and the Risk for Rejection-Related Graft Failure of Kidney Allografts
por: Betjes, Michiel G. H., et al.
Publicado: (2020)

Donor-derived Cell-free DNA Identifies Antibody-mediated Rejection in Donor Specific Antibody Positive Kidney Transplant Recipients
por: Jordan, Stanley C., et al.
Publicado: (2018)

Association of non-HLA antibodies against endothelial targets and donor-specific HLA antibodies with antibody-mediated rejection and graft function in pediatric kidney transplant recipients
por: Fichtner, Alexander, et al.
Publicado: (2021)

Safety and efficacy of eculizumab for the prevention of antibody‐mediated rejection after deceased‐donor kidney transplantation in patients with preformed donor‐specific antibodies
por: Glotz, Denis, et al.
Publicado: (2019)

Clinical significance of de novo donor-specific antibody in kidney transplant recipients with chronic antibody-mediated rejection
por: Park, Woo Yeong, et al.
Publicado: (2021)

Antibody-Mediated Rejection in Kidney Transplantation: A Retrospective Study on the Impact of Donor-Specific Antibodies and on the Timing of Diagnosis
por: Reis Pereira, Pedro, et al.
Publicado: (2022)

The impact of preformed donor‐specific antibodies in living donor liver transplantation according to graft volume
por: Goto, Ryoichi, et al.
Publicado: (2022)

Combining donor-derived cell-free DNA and donor specific antibody testing as non-invasive biomarkers for rejection in kidney transplantation
por: Obrișcă, Bogdan, et al.
Publicado: (2022)

Class and Kinetics of Weakly Reactive Pretransplant Donor-specific HLA Antibodies Predict Rejection in Kidney Transplant Recipients
por: Morrison, Alexander H., et al.
Publicado: (2019)

Treatment of donor‐specific antibody‐mediated rejection after heart transplantation by IgM‐enriched human immunoglobulin
por: Immohr, Moritz Benjamin, et al.
Publicado: (2021)

Belatacept Treatment of Recurrent Late-onset T Cell–mediated Rejection/Antibody-mediated Rejection With De Novo Donor-specific Antibodies in a Liver Transplant Patient
por: Klintmalm, Göran B., et al.
Publicado: (2022)

How Do We Interpret the Presence of Donor-Specific Antibodies When There Is No Rejection?
por: Crew, R. John, et al.
Publicado: (2019)

Donor-Specific Antibodies in the Absence of Rejection Are Not a Risk Factor for Allograft Failure
por: Parajuli, Sandesh, et al.
Publicado: (2019)

Role of biliary complications in chronic graft rejection after living donor liver transplantation
por: Obed, Aiman, et al.
Publicado: (2022)

Impact of donor-specific antibodies on long-term graft survival with pediatric liver transplantation
por: Schotters, Felicitas Leonie, et al.
Publicado: (2021)

Role of de novo DQ donor-specific antibody in antibody-mediated rejection in renal transplant recipient: A case study
por: Chowdhry, Mohit, et al.
Publicado: (2019)

Subclass analysis of donor HLA‐specific IgG in antibody‐incompatible renal transplantation reveals a significant association of IgG(4) with rejection and graft failure
por: Khovanova, Natasha, et al.
Publicado: (2015)

Preformed Donor-specific Antibodies Against HLA Class II and Graft Outcomes in Deceased-donor Kidney Transplantation
por: Uffing, Audrey, et al.
Publicado: (2019)

Clinical significance of donor-specific anti-HLA-DR51/52/53 antibodies for antibody-mediated rejection in kidney transplant recipients
por: Park, Borae Geum, et al.
Publicado: (2019)

Donor Specific Anti-HLA Antibody and Risk of Graft Failure in Haploidentical Stem Cell Transplantation
por: Kongtim, Piyanuch, et al.
Publicado: (2016)

Immunology and Donor-Specific Antibodies in Corneal Transplantation
por: Major, Joanna, et al.
Publicado: (2021)

Highly Variable Sialylation Status of Donor-Specific Antibodies Does Not Impact Humoral Rejection Outcomes
por: Barba, Thomas, et al.
Publicado: (2019)

Donor-Specific Cell-Free DNA qPCR Quantification as a Noninvasive Accurate Biomarker for Early Rejection Detection in Liver Transplantation
por: García-Fernández, Noelia, et al.
Publicado: (2022)

Synergistic impact of pre-sensitization and delayed graft function on allograft rejection in deceased donor kidney transplantation
por: Lee, Hanbi, et al.
Publicado: (2021)

Donor–specific HLA-DQ antibodies may contribute to poor graft outcome after heart transplantation
por: Omrani, Osama, et al.
Publicado: (2018)

Pretransplant Donor-specific IFNγ ELISPOT as a Predictor of Graft Rejection: A Diagnostic Test Accuracy Meta-analysis
por: Montero, Nuria, et al.
Publicado: (2019)

Consideraciones de operación de un reactor BW R
por: Reyes Cruz, Miguel Angel
Publicado: (1992)

Recurrent Mild Acute Rejections and Donor-specific Antibodies as Risk Factors for Cardiac Allograft Vasculopathy in a National Pediatric Heart Transplant Cohort
por: Kaskinen, Anu K., et al.
Publicado: (2023)

Post-transplant donor-specific anti-HLA antibodies with a higher mean fluorescence intensity are associated with graft fibrosis in pediatric living donor liver transplantation
por: Goto, Ryoichi, et al.
Publicado: (2023)

Diagnostic value of donor‐derived cell‐free DNA to predict antibody‐mediated rejection in donor‐specific antibody‐positive renal allograft recipients
por: Mayer, Katharina A., et al.
Publicado: (2021)

Antibody-mediated Rejection Without Detectable Donor-specific Antibody Releases Donor-derived Cell-free DNA: Results From the Trifecta Study
por: Halloran, Philip F., et al.
Publicado: (2023)

Correlation of Pretransplant Donor-specific Antibody Assay Using Luminex Crossmatch with Graft Outcome in Renal Transplant Patients
por: Vimal, M., et al.
Publicado: (2017)

Management of Donor-Specific Antibodies in Haploidentical Transplant: Multicenter Experience From the Madrid Group of Hematopoietic Transplant
por: Bailén, Rebeca, et al.
Publicado: (2021)

Scientific opinion on Prosmoke BW 01
por: Younes, Maged, et al.
Publicado: (2022)

Biologically Unrelated Living Donor for Kidney Transplantation Associated With Higher Acute Rejection Rate but With Similar Graft Survival of a Related Living Donor
por: Reis Pereira, Pedro, et al.
Publicado: (2022)

Donor derived hematopoietic stem cell niche transplantation facilitates mixed chimerism mediated donor specific tolerance
por: Zhang, Wensheng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ktk47jo6nnvcit3kp66osakgi7